Similar articles

• [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].

  Cherchi A, Sau F, Mercuro G, Seguro C, Lai O. Cherchi A, et al. Clin Ter. 1985 May 31;113(4):301-6. Clin Ter. 1985. PMID: 3893868 Clinical Trial. Italian. No abstract available.
• [Evaluation of the antihypertensive effect and tolerability of nadolol administered alone or in association with bendroflumethiazide].

  Gragnoli G, Righi GA, Turchetti V, Mondillo S, Kristodhullu A. Gragnoli G, et al. Minerva Med. 1984 Nov 10;75(43):2609-15. Minerva Med. 1984. PMID: 6392936 Clinical Trial. Italian.
• Timolol and bendroflumethiazide in the treatment of hypertension.

  Karatzas NB, Papazachos G, Clouva P, Tsaknakis T. Karatzas NB, et al. J Int Med Res. 1979;7(3):215-20. doi: 10.1177/030006057900700308. J Int Med Res. 1979. PMID: 378730 Clinical Trial. No abstract available.
• A new beta-adrenergic blocking drug in hypertension. A report from the General Practitioner Research Group.

  [No authors listed] [No authors listed] Practitioner. 1976 Feb;216(1292):218-21. Practitioner. 1976. PMID: 772659 Clinical Trial.
• [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].

  Marchetta F, Chiarini C, Degli Esposti E, Santoro A, Sturani A, Zuccalà A, Zucchelli P. Marchetta F, et al. Clin Ter. 1983 Aug 15;106(3):209-12. Clin Ter. 1983. PMID: 6627892 Italian. No abstract available.